Clinical trial
Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI…
NCT00178854 · Vanderbilt University Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00178854 |
|---|---|
| Title | Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment |
| Official title | Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Collaborators | Janssen, LP Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Treatment Resistant Depression |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 0 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: